Why Basel Medical Group Ltd’s (BMGL) Stock Is Up 5.64%
As of Thursday, July 02, Basel Medical Group Ltd’s BMGL share price has surged by 5.64%, which has investors questioning if this is right time to sell.Michael Rose
Stock Evaluator: Basel Medical Group Ltd (BMGL)
Basel Medical Group Ltd BMGL
$3.28
0.26
8.61%
October 2, 2026 4:00:00 PM
EST
Volume: 25,178
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, including trauma and sports medicine services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures, as well as neurosurgical treatments. It also provides health screening services, mental health, woman’s health, and general practice services. In addition, its services include consultation, medical diagnosis, and medical and surgical treatments. The company was incorporated in 2023 and is headquartered in Singapore.
Commentary & Analysis
Why Basel Medical Group Ltd’s (BMGL) Stock Is Down 7.14%
As of Friday, July 18, Basel Medical Group Ltd’s BMGL share price has dipped by 7.14%, which has investors questioning if this is right time to buy.Jenna Brashear
Why Basel Medical Group Ltd’s (BMGL) Stock Is Down 14.28%
As of Friday, July 18, Basel Medical Group Ltd’s BMGL share price has dipped by 14.28%, which has investors questioning if this is right time to buy.Jenna Brashear
Why Basel Medical Group Ltd’s (BMGL) Stock Is Up 5.86%
As of Thursday, July 17, Basel Medical Group Ltd’s BMGL share price has surged by 5.86%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Basel Medical Group Ltd’s (BMGL) Stock Is Down 10.46%
As of Tuesday, July 15, Basel Medical Group Ltd’s BMGL share price has dipped by 10.46%, which has investors questioning if this is right time to buy.Jenna Brashear
Financial Summary
| Share Statistics | BMGL | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $5.2 | $1,687.3 | 4% |
|
| Shares Out (Mil) | 1.2 | 77.7 | 5% |
|
| Institutional Ownership | 0.5% | 87.7% | 1% |
|
| Float (Mil) | 0.5 | 56.1 | 1% |
|
| Beta | na | 0.81 | na |
|
| Avg Daily Volume (000s) | 36 | 614 | 25% |
|
| Price Change (52-week) |
(84.9%) | 76.5% | 6% |
|
| Growth | BMGL | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 10.6% | na |
|
| Net Income (5yr) | na | (0.3%) | na |
|
| EPS (5yr) | na | 3.0% | na |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (17.3%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | BMGL | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $12 | $1,505 | 10% |
|
| Net Income (TTM) (Mil) | ($8) | $26 | 31% |
|
| EPS (TTM) | ($4.675) | $0.200 | 8% |
|
| Operating Cash Flow (TTM) (Mil) | ($2) | $157 | 30% |
|
| Net Cash Flow (TTM) (Mil) | ($5) | $2 | 34% |
|
| Long-Term Debt (Q1) (Mil) | $5 | $374 | 24% |
|
| Enterprise Value (Q1) (Mil) | $6 | $2,284 | 6% |
|
| Valuation | BMGL | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.05 | 2.90 | 25% |
|
| P/E | na | 25.2 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.0 | na |
|
| Ratios | BMGL | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 14.0% | 27.6% | 13% |
|
| Net Margin | (68.2%) | 1.2% | 10% |
|
| ROA | (58.8%) | 2.1% | 10% |
|
| ROE | (153.2%) | 6.9% | 6% |
|
| Liabilities to Assets | 67.6% | 60.8% | 63% |
|
| F-Score | 3 | 5 | na |
|
Basel Medical Group Ltd did not pass any screens on 10/2/2026.
